ArticleJournal of the Pediatric Orthopaedic Society of North America2024
Bone equilibria and disruptions.
Article in Journal of the Pediatric Orthopaedic Society of North America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteoporosis is considered a disease of adulthood, but there is increasing recognition that poor bone density during childhood can have effects decades later. To understand the pathogenesis of osteoporosis, it is important to understand normal bone maintenance and remodeling, since disruptions of these processes lead to pathologic bone. Bone maintenance is a complex and highly regulated system, consisting of several homeostatic equilibria. This article highlights three homeostatic systems. The first, the interplay between the differentiation of osteoblasts from mesenchymal stem cells and osteoclasts from hematopoietic stem cells, is the most important. Estrogen has a direct effect on the system, and its absence is pivotal. The second is a lesser-known homeostasis that functions between bone and bone marrow adipose tissue, which can insidiously drive osteoporosis. Bone marrow adipose tissue acts as a regulator of bone metabolism, negatively affecting bone formation. The third homeostatic system covered is the microbiota-gut-bone axis, where the make-up of the gut microbiome can influence a balance between osteoblastic and osteoclastic T-cells. Understanding these systems has provided avenues of study for existing and future treatments. Key Concepts: (1)The balance between bone formation and bone resorption is driven by factors that initiate the differentiation of mesenchymal stem cells to osteoblasts and hematopoietic stem cells to osteoclasts.(2)Bone marrow adipose tissue is formed by adipocytes that are the result of diversion of mesenchymal stem cells from the osteoblastic differentiation pathway.(3)The health of the gut microbiome has direct effects on the bone homeostatic processes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.